142 related articles for article (PubMed ID: 20521320)
21. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene.
Chowdhury NI; Tiwari AK; Souza RP; Zai CC; Shaikh SA; Chen S; Liu F; Lieberman JA; Meltzer HY; Malhotra AK; Kennedy JL; Müller DJ
Pharmacogenomics J; 2013 Jun; 13(3):272-9. PubMed ID: 22310352
[TBL] [Abstract][Full Text] [Related]
22. Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response.
Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; MacNeil LT; Culotti JG; Kennedy JL; Wong AH
J Psychiatr Res; 2010 Aug; 44(11):700-6. PubMed ID: 20116071
[TBL] [Abstract][Full Text] [Related]
23. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL
Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421
[TBL] [Abstract][Full Text] [Related]
24. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
Popp J; Leucht S; Heres S; Steimer W
Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
[TBL] [Abstract][Full Text] [Related]
25. Clozapine and weight gain.
Umbricht DS; Pollack S; Kane JM
J Clin Psychiatry; 1994 Sep; 55 Suppl B():157-60. PubMed ID: 7961563
[TBL] [Abstract][Full Text] [Related]
26. -759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain.
Tsai SJ; Hong CJ; Yu YW; Lin CH
Lancet; 2002 Nov; 360(9347):1790. PubMed ID: 12480466
[No Abstract] [Full Text] [Related]
27. Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia.
Ferrari M; Bolla E; Bortolaso P; Callegari C; Poloni N; Lecchini S; Vender S; Marino F; Cosentino M
Psychiatry Res; 2012 Dec; 200(2-3):1014-7. PubMed ID: 22901441
[TBL] [Abstract][Full Text] [Related]
28. C825T polymorphism in the human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in the Chinese population.
Wang YC; Bai YM; Chen JY; Lin CC; Lai IC; Liou YJ
Pharmacogenet Genomics; 2005 Oct; 15(10):743-8. PubMed ID: 16141801
[TBL] [Abstract][Full Text] [Related]
29. Dopamine D4 receptor gene exon III polymorphism and interindividual variation in response to clozapine.
Zhao AL; Zhao JP; Zhang YH; Xue ZM; Chen JD; Chen XG
Int J Neurosci; 2005 Nov; 115(11):1539-47. PubMed ID: 16223700
[TBL] [Abstract][Full Text] [Related]
30. Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain.
Brandl EJ; Tiwari AK; Lett TA; Shaikh SA; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
Hum Psychopharmacol; 2013 Mar; 28(2):183-7. PubMed ID: 23364847
[TBL] [Abstract][Full Text] [Related]
31. [Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].
Zhang Z; Zhang X; Yao Z; Chen J; Sun J; Yao H; Hou G; Zhang X; Reynolds GP
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1097-101. PubMed ID: 12425817
[TBL] [Abstract][Full Text] [Related]
32. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals.
Theisen FM; Hinney A; Brömel T; Heinzel-Gutenbrunner M; Martin M; Krieg JC; Remschmidt H; Hebebrand J
Psychiatr Genet; 2004 Sep; 14(3):139-42. PubMed ID: 15318026
[TBL] [Abstract][Full Text] [Related]
33. Risperidone-related weight gain: genetic and nongenetic predictors.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
[TBL] [Abstract][Full Text] [Related]
34. Genetic predictors of antipsychotic-induced weight gain: a case-matched multi-gene study.
Wu R; Zhao J; Shao P; Ou J; Chang M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 36(8):720-3. PubMed ID: 21937795
[TBL] [Abstract][Full Text] [Related]
35. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR
J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
[TBL] [Abstract][Full Text] [Related]
36. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
37. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
Güzelcan Y; Scholte WF
Tijdschr Psychiatr; 2006; 48(4):295-302. PubMed ID: 16955993
[TBL] [Abstract][Full Text] [Related]
38. [Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain].
Zhang ZJ; Yao ZJ; Mou XD; Chen JF; Zhu RX; Liu W; Zhang XR; Sun J; Hou G
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2119-23. PubMed ID: 14720418
[TBL] [Abstract][Full Text] [Related]
39. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
40. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.
Zhang ZJ; Yao ZJ; Zhang XB; Chen JF; Sun J; Yao H; Hou G; Zhang XB
Acta Pharmacol Sin; 2003 Mar; 24(3):235-40. PubMed ID: 12617772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
